EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Efficacy of IgM-Enriched Immunoglobulin (eIg) Administration for Treatment of Sepsis and Septic Shock in Adult Surgical Patients: A Single-Center, Retrospective, Observational Study

Die Wirksamkeit von IgM-angereicherten Immunglobulinen (eIg) zur Behandlung von Sepsis und septischem Schock bei erwachsenen chirurgischen Patient:innen: eine single-center, retrospektive Beobachtungsstudie

Serena Spanò, Gabriella Licitra iD, Giada Cucciolini iD, Etrusca Brogi iD, Rita Martinelli, Francesco Cundari, Maria Giovanna Curci, Federico Coccolini, Stefano Busani iD, Giorgio Berlot iD, Mattia Bixio iD, Gianni Biancofiore iD und 2 weitere

Journal of Clinical Medicine · 14.02.2026 · 15 (4) · 1526

DOI: 10.3390/jcm15041526 ↗

Auf einen Blick

Bei 108 chirurgischen Patient:innen mit Sepsis oder septischem Schock war eIg mit geringerer ICU- und In-hospital-Mortalität verbunden. Die ICU-Verweildauer und die Beatmungsdauer waren länger.

Fragestellung

Beeinflusst die Gabe von IgM-angereicherten Immunglobulinen (eIg) das Outcome erwachsener chirurgischer Patient:innen mit Sepsis oder septischem Schock?

Methode

Single-center, retrospektive, beobachtende Studie in der ICU des Pisa University Hospital von Januar 2016 bis Dezember 2019; Propensity Score mittels inverse probability weighting.

Ergebnisse

108 Patient:innen. eIg vs. keine eIg: ICU-Mortalität ATE −0,17 (95 %-KI −0,33 bis −0,03; p = 0,023), In-hospital-Mortalität ATE −0,18 (95 %-KI −0,34 bis −0,03; p = 0,022). ICU-Verweildauer + 7,1 Tage und Beatmungsdauer + 4,5 Tage.

Einschränkungen

Beobachtungsstudie mit den üblichen Einschränkungen; nur gemessene Confounder wurden berücksichtigt.

Schlussfolgerung der Autor:innen

Die Autor:innen schließen, dass eIg trotz der methodischen Einschränkungen die ICU- und In-hospital-Mortalität bei chirurgischen Patient:innen mit Sepsis und septischem Schock senken könnte.

Kernaussagen

  • eIg war mit geringerer ICU-Mortalität verbunden
  • In-hospital-Mortalität ebenfalls niedriger unter eIg
  • ICU-Verweildauer und Beatmungsdauer waren länger

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.02.2026. Verfasst von Serena Spanò und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, 56126 Pisa, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Surgical sepsis, particularly secondary peritonitis, is a leading cause of ICU admissions, with mortality rates reaching 40%. In recent decades, several adjuvant therapies have been proposed in addition to standard of care to modulate the inflammatory response and support organ function. In our study, we aimed to evaluate the efficacy of IgM-enriched immunoglobulin (eIg) treatment on outcome of adult surgical patients with sepsis and septic shock.

Methods

A single-center, retrospective, observational study was conducted from January 2016 to December 2019 in the Intensive Care Unit of Pisa University Hospital. Patients with sepsis or septic shock resulting from primary or postoperative infections undergoing surgical source control were included. The primary outcome was to investigate the impact of eIg administration on in-hospital mortality. The secondary outcomes were the ICU length of stay, days of ventilation, and vasoactive drug administration. A propensity score through inverse probability weighting was used to control for measured confounding variables.

Results

A total of 108 patients, categorized into two groups based on whether they received eIg, were included during the study period. Compared to the untreated group, patients who received eIg showed a significant reduction in ICU mortality (ATE −0.17, 95% CI −0.33 to −0.03; p = 0.023) and in-hospital mortality (ATE −0.18, 95% CI −0.34 to −0.03; p = 0.022). However, the ICU length of stay and the duration of mechanical ventilation were significantly longer in the treated group (ATE + 7.1 days, 95% CI 3.1 to 11.1; p = 0.001 and ATE + 4.5 days, 95% CI 1.0 to 7.9; p = 0.011, respectively). No other statistically significant differences were observed.

Conclusions

Despite the significant limitations of its observational nature, our study suggests that administering eIg may reduce ICU and in-hospital mortality in surgical patients with sepsis and septic shock.

Schlagwörter

Stichwörter der Autor:innen

ICUIgGAM (Pentaglobin®)IgM-enriched immunoglobulinaverage treatment effect (ATE)eIgmortalitypropensity weighting score analysissepsissepsis dysfunctionseptic shocksurgical patients

Autor:innen und Institutionen

  • Department of Anesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, 56126 Pisa, Italy.
  • Intensive Care Unit, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.
  • General, Emergency and Trauma Surgery Department, Pisa University Hospital, 56100 Pisa, Italy.
  • Anesthesia and Intensive Care Department, University Hospital of Modena, University of Modena, 41125 Reggio Emilia, Italy.
  • Department of Anesthesia and Intensive Care, Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • Department of Transplant Anesthesia and Critical Care, University School of Medicine, 56126 Pisa, Italy.

ORCID-Profile: Gabriella Licitra, Giada Cucciolini, Etrusca Brogi, Stefano Busani, Giorgio Berlot, Mattia Bixio, Gianni Biancofiore, Francesco Corradi, Francesco Forfori

Zitieren

APA

Spanò, S., Licitra, G., Cucciolini, G., Brogi, E., Martinelli, R., Cundari, F., Curci, M. G., Coccolini, F., Busani, S., Berlot, G., Bixio, M., Biancofiore, G., Corradi, F., & Forfori, F. (2026). The Efficacy of IgM-Enriched Immunoglobulin (eIg) Administration for Treatment of Sepsis and Septic Shock in Adult Surgical Patients: A Single-Center, Retrospective, Observational Study. Journal of Clinical Medicine, 15(4), 1526. https://doi.org/10.3390/jcm15041526

Vancouver

Spanò S, Licitra G, Cucciolini G, Brogi E, Martinelli R, Cundari F, et al. The Efficacy of IgM-Enriched Immunoglobulin (eIg) Administration for Treatment of Sepsis and Septic Shock in Adult Surgical Patients: A Single-Center, Retrospective, Observational Study. Journal of Clinical Medicine. 2026;15(4):1526. doi:10.3390/jcm15041526

BibTeX
@article{Span2026,
  author = {Spanò, Serena and Licitra, Gabriella and Cucciolini, Giada and Brogi, Etrusca and Martinelli, Rita and Cundari, Francesco and Curci, Maria Giovanna and Coccolini, Federico and Busani, Stefano and Berlot, Giorgio and Bixio, Mattia and Biancofiore, Gianni and Corradi, Francesco and Forfori, Francesco},
  title = {The Efficacy of IgM-Enriched Immunoglobulin (eIg) Administration for Treatment of Sepsis and Septic Shock in Adult Surgical Patients: A Single-Center, Retrospective, Observational Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {1526},
  doi = {10.3390/jcm15041526}
}
Kostenlos starten →